Listen to Snap Inc. (NYSE: SNAP) Q3 2020 earnings call dated Oct. 20, 2020
Corporate Participants:
Betsy Miller Frank — Head of Investor Relations
Evan Spiegel — Chief Executive Officer
Jeremi Gorman — Chief Business Officer
Derek Andersen — Chief Financial Officer
Analysts:
Ross Sandler — Barclays — Analyst
Doug Anmuth — JPMorgan — Analyst
Michael Levine — Pivotal Research Group — Analyst
Heath Terry — Goldman Sachs — Analyst
Rich Greenfield — LightShed Partners — Analyst
Justin Post — Bank of America Merrill Lynch — Analyst
Eric Sheridan — UBS — Analyst
Brian Nowak — Morgan Stanley — Analyst
Mark Shmulik — Bernstein — Analyst
Read the full earnings transcript at https://news.alphastreet.com/snap-inc-snap-q3-2020-earnings-call-transcript/
Most Popular
Context Therapeutics: Another clinical-stage oncology research firm to go public soon
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for
Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant
IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
Listen On
